Skip to main content
S&P 5007,722.60+0.60%DOW52,377.57+0.03%NASDAQ26,477.81+1.18%BTC$80,669.00+0.42%ETH$2,336.72+0.02%GOLD$4,068.00-0.16%OIL$101.97+2.07%
Smart Investors Daily
SID Premium
RP

NASDAQ · RPID

Rapid Micro Biosystems, Inc.

Healthcare · Medical - Devices

$0.79

Up+$0.00 (+0.31%)

Updated Oct 28, 2026, 12:55 PM

SID Score

2.7/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
164.95M
P/E ratio
-3.74
Dividend yield
0.00%
52-week range
$0.76 – $4.47
Volume
97.95K
Avg. volume
97.66K

Price performance · RPID

RPID price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 27, 2026

RPID closed at $0.79 after 21 trading sessions, down 27.09% for the selected period.

Last close
$0.79
Period change
-27.09%
Period low
$0.76
Period high
$1.08
Daily close
View OHLC price history
RPID OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 27, 2026$0.77$0.8095$0.77$0.787497.95K
Oct 26, 2026$0.785$0.8124$0.7735$0.78535.06K
Oct 23, 2026$0.7975$0.7976$0.7763$0.7852.66K
Oct 22, 2026$0.83$0.85$0.778$0.801127.17K
Oct 21, 2026$0.7785$0.8261$0.761$0.816279.62K
Oct 20, 2026$0.7612$0.82$0.7612$0.7717108.24K
Oct 19, 2026$0.80$0.8147$0.7601$0.7736198.06K
Oct 16, 2026$0.8231$0.838$0.76$0.7644356.7K
Oct 15, 2026$0.83$0.856$0.81$0.845187.62K
Oct 14, 2026$0.8476$0.8768$0.8088$0.8173145.15K
Oct 13, 2026$0.88$0.9139$0.8349$0.8738168.26K
Oct 12, 2026$0.89$0.90$0.8561$0.8788100.97K
Oct 9, 2026$0.8755$0.9177$0.8604$0.8935214.53K
Oct 8, 2026$0.912$0.912$0.8255$0.8617227.36K
Oct 7, 2026$0.9722$0.9944$0.891$0.8977218.86K
Oct 6, 2026$1.00$1.00$0.9426$0.9426162.26K
Oct 5, 2026$0.9122$1.15$0.9122$0.9764444.78K
Oct 2, 2026$0.96$0.9999$0.8604$0.92329.28K
Oct 1, 2026$1.06$1.06$0.919$0.921525.66K
Sep 30, 2026$1.10$1.10$1.03$1.03179.9K
Sep 29, 2026$1.18$1.1801$1.065$1.08334.27K

Latest RPID news

The latest Smart Investors Daily articles mentioning RPID.

Stock researchCompany · Overview

RPID research

Overview

Company profile and research snapshot.

Company profile

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$8.00
Implied upside
—
Analysts
—
RPID recent ratings
DateFirmRatingTarget
Sep 29, 2026Roth CapitalBuy—
May 29, 2026KeybancOverweight—
May 22, 2026Lake StreetBuy—
Jul 28, 2025Lake StreetBuy—
Feb 12, 2025KeybancOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 20, 2026

Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026

LEXINGTON, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its participation as a sponsor of the PDA Pharmaceutical Microbiology Conference 2026, taking place in Washington, D.C. from October 26-28. The conference brings together microbiology pro

Yahoo · Sep 4, 2026

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced plans to participate in the following upcoming investor conferences: Thursday, September 10, 2026 - Lake Street’s 10th Annual Best Ideas Growth (BIG) Conference in New York, NY. The Comp

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By